St. Jude Medical S.C., Inc. v. Janssen-Counotte

104 F. Supp. 3d 1150, 91 Fed. R. Serv. 3d 1495, 2015 U.S. Dist. LEXIS 64355, 2015 WL 2359568
District Court, D. Oregon·Decided May 18, 2015·No. Case No. 3:15-mc-00099-SI·Published·Cited by 11 cases

Opinion

OPINION AND ORDER ON MOTION FOR RECONSIDERATION OR TRANSFER

MICHAEL H. SIMON, District Judge.

Plaintiff St. Jude Medical S.C., Inc. (“St. Jude” or “St. Jude U.S.”) previously brought a motion to compel compliance with a third-party subpoena that it served upon Biotronik, Inc. (“Biotronik” or “Bio-tronik U.S.”). After that motion was fully briefed and argued, the Court granted St. Jude’s motion in part and appointed a special master to assist in resolving the remainder of the issues. Dkts. 19, 20. Biotronik now moves the Court to reconsider its decision or to transfer the dispute to the Western District of Texas, where the underlying, principal case is pending. The Court has considered the parties’ arguments as set forth in their memoranda and supporting materials. For the reasons stated below, Biotronik’s motion is DENIED.

BACKGROUND

The parties and events leading to the present motion are adequately chronicled in the Court’s prior Opinion and Order dated March 23, 2015. Dkt. 19 at 2-11. For ease of understanding the Court’s res[1157] olution of the pending motion, however, the parties and their relationships relevant to this motion are briefly stated as follows:

• St. Jude U.S. and Biotronik U.S. are both members of multinational corporate groups that compete in the worldwide medical-technology market.
• Biotronik U.S. is owned by MS Holding II SE, a German company. MS Holding II SE also owns Biotronik SE & Co. KG (“Biotronik SE”), a German company. Biotronik AG is another European company affiliated with Bio-tronik U.S/
• Defendant Louise Marie Janssen-Counotte (“Janssen”) was previously employed as a vice president by St. Jude U.S.’s European affiliates and is now president of Biotronik U.S.
• The “Biotronik Group,” as defined in Janssen’s employment agreement, includes Biotronik U.S. and all of its affiliated companies, including Biotro-nik SE, Biotronik AG, and MS Holding II SE.
• Max Schaldach is the beneficial owner of the entire Biotronik Group. Christian Bluemel and Werner Braun are also high-level executives of companies within the Biotronik Group. Janssen negotiated her employment by Biotro-nik U.S. with Messrs. Schaldach, Bluemel, and Braun.

DISCUSSION

Biotronik argues that the Court erred on two counts: first, in holding that Bio-tronik U.S. had “control,” within the meaning of Rule 45 of the Federal Rules of Civil Procedure, over certain documents held by its European affiliates; and second, in permitting St. Jude to proceed with its third-party subpoena without disclosing which particular trade secrets it alleges were stolen. Biotronik also invokes for the first time the application of the Hague Convention on the Taking of Evidence in Civil or Commercial Matters (“Hague Evidence Convention” or “Convention”), opened for signature March 18, 1970, 23 U.S.T. 2555. Finally, despite having litigated the merits of this discovery dispute in this Court and not having previously consented to this discovery dispute being heard by the court presiding over the principal case, Biotronik now moves to transfer this discovery dispute to the Western District of Texas after having lost on the merits of most of its arguments.

A. Rule 45 and the Meaning of “Control”

In its motion for reconsideration, Biotro-nik argues that, among other things, the Court misapplied the Ninth Circuit’s standard in In re Citric Acid Litigation, 191 F.3d 1090 (9th Cir.1999), for when a corporate entity has “control” over documents that are owned by and in the possession of a legally distinct entity. According to Bio-tronik,

In Citric Acid, the Ninth Circuit ruled that a party lacks legal control over documents in the possession of an affiliated entity where the affiliates in question are separate entities under the law and any contract governing the parties’ relationship does not expressly give the subpoenaed party the right to obtain the records upon demand. 191 F.3d at 1107 (discussing United States v. International Union of Petroleum & Indus. Workers, 870 F.2d 1450, 1452 (9th Cir.1989)).

Dkt. 25 at 9. Biotronik adds that “[t]he Court here did not apply this standard” and that “[t]he facts of Citric Acid are remarkably similar to those present here.” Id. at 9-10.

Biotronik is incorrect on both points. The Court correctly applied the Ninth Circuit’s standard in Citric Acid, [1158] and the facts of that case are not relevantly similar to the present dispute. Indeed, it is this factual distinction that explains how this. Court correctly applied the Citric Acid standard yet arrived at a different result. In short, Citric Acid involved a contractual relationship among affiliated entities and the parties’ contract did not providé that one party had the right to control documents owned by the other. There was no agency relationship alleged in Citric Acid. In relevant contrast here, St. Jude has shown that a principal-agent relationship exists here, and it is a basic premise of the law governing principal-agent relations that an agent must comply with the lawful directives of the principal concerning matters within the agency relationship. ' Thus, the case pending before this Court involving St. Jude and Biotro-nik, unlike Citric Acid, does present the “right to control” documents owned by another (namely, the agent of the subpoenaed party) and thereby satisfies the control requirement set forth in Citric Acid.

Free access — add to your briefcase to read the full text and ask questions with AI

St. Jude Medical S.C., Inc. v. Janssen-Counotte, 104 F. Supp. 3d 1150, 91 Fed. R. Serv. 3d 1495, 2015 U.S. Dist. LEXIS 64355, 2015 WL 2359568 (D. Or. 2015).

104 F. Supp. 3d 1150 (St. Jude Medical S.C., Inc. v. Janssen-Counotte) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related